Agreement, Etc Clause Samples

The "Agreement etc" clause serves to formally establish the existence of a binding contract between the parties and to define the scope of the agreement. Typically, this clause specifies that the document constitutes the entire agreement, superseding any prior discussions or understandings, and may clarify which documents or schedules are incorporated by reference. Its core practical function is to ensure that all parties are clear on the terms that govern their relationship, thereby reducing the risk of disputes over what has been agreed upon.
Agreement, Etc. A duly executed copy of this agreement and all instruments and documents contemplated hereby.
View SourceView Similar (4)
Agreement, Etc to be read as a whole
View SourceView Similar (4)
Agreement, Etc. This Agreement constitutes the valid and binding obligation of such DF Participant and the funds deposited by him in the DF Escrow Account are funds which he may properly apply for the purposes set forth herein.
View Source
Agreement, Etc. Each of NCI and the Buyer has all requisite corporate power and authority to enter into this Agreement, to consummate the transactions contemplated hereby and perform its obligations hereunder. This Agreement has been duly authorized, executed and delivered by NCI and the Buyer and constitutes the legal and binding obligation of NCI and the Buyer
View Source
Agreement, Etc. As the tour operator, SkiStar is responsible for providing the guest with pro- ductsand services as specified intheagreement.Thisresponsibility alsoapplies to services etc. to be provided by parties other than SkiStar. Information in catalogues, brochures and on the website are binding for SkiStar, but may be changed before an agreement is entered into if reservations have been clearly made and the guest has been duly informed about the change. SkiStar is not responsible for possible printing or proofing errors. As the tour operator, SkiStar is responsible for ensuring: • that the guest receiveswritten confirmation of his booking and other important documents; • that information is provided on the method of payment and that the guest is informed about any other matters of significance relating to the arrangement; • that the arrangement corresponds to the description in the booking confir- ▇▇▇▇▇▇. SkiStar is not responsible for promises that may have been made by third parties directly to the guest without SkiStar’s knowledge and that SkiStar is not aware of nor should be aware of. SkiStar recommends that the guest tries to get this type of information in writing. In these general booking terms and conditions the followingdefinitionsapply: Departure - the point in time specified on the confirmation/travel document Arrival - the point in time specified on the confirmation Home journey - the point in time specified on the confirmation/travel do- cument First day of validity - the date when use of e.g. the SkiPass and any additional products is to commence.
View Source
Agreement, Etc. Each of the Sellers has all requisite corporate power and authority to enter into this Agreement, to consummate the transactions contemplated hereby and perform its obligations hereunder. This Agreement has been duly executed and delivered by the Sellers and constitutes the legal and binding obligation of the Sellers enforceable in accordance with its terms. The execution and delivery by the Sellers of this Agreement, the consummation of the transactions contemplated hereby, and the performance by the Sellers of their respective obligations hereunder will not conflict with or result in any violation of, or any default under (either immediately or with notice or lapse of time), or any right to accelerate or the creation of any lien, charge or encumbrance pursuant to, any provision of (a) the respective certificates of incorporation or by-laws of the Sellers, (b) any agreement, contract, mortgage, lease, license, note, bond, indenture, deed of trust or other instrument to which the Sellers or either of them is a party or by which any of the Assets are bound, (c) any governmental franchise, license, permit or authorization, or any judgment or order of any tribunal or governmental body applicable to the Sellers or any of the Assets, or (d) any law, statute, decree, rule or regulation of any jurisdiction. No authorization, consent or approval of, or declaration of, filing with or notice to any governmental body or authority by the Sellers is necessary for the execution of this Agreement by the Sellers, the consummation by the Sellers of the transactions contemplated
View Source
Agreement, Etc. As the Organiser, SkiStar is responsible to the Guest for what the latter has ordered under the agreement. This responsibility also applies to services to be provided by parties other than SkiStar as long as they are included in the Arrangement. SkiStar operates in accordance with the established Code of Conduct, which can be found at here. SkiStar is bound by information in catalogues, brochures and on the SkiStar website, however this information may be changed before an agreement is entered into if the Guest has been duly informed about the change. SkiStar reserves the right to make any printing or correction errors. Both before and after the agreement is concluded, SkiStar may make minor changes to the Arrangement. In this case, SkiStar shall inform the Guest. Please refer as well to the current SLAO regulations, including the skiing and cycling rules in the SLAO Little Yellow and SLAO Little Green, which can be found on the SLAO website, ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇/fakta/utforsakarens- trafikregler/. Both the skiing and cycling rules and other applicable industry regulations issued by SLAO form part of the agreement between SkiStar and the Guest/ Travelling Companion/Subscriber. These rules also apply to summer skiing. In the event of conflict between ▇▇▇▇'s skiing and cycling rules, other industry regulations and these general booking terms, these general booking terms shall take precedence. As the Tour Operator, SkiStar is responsible for ensuring that: • The Guest receives a written Booking Confirmation and other necessary documents, such as rules of conduct, general industry regulations issued by the SLAO, including skiing rules (see link above), etc. • Information is provided about the method of payment and where to collect keys, and the Guest is informed about any other matters of significance for the provision of the Arrangement. • The Arrangement corresponds to the description in the Booking Confirmation. SkiStar is not responsible for promises that may have been made by third parties directly to the Guest without SkiStar’s knowledge and which SkiStar is not aware of nor should be aware of. SkiStar recommends that the Guest receives that type of information in writing. • The Guest will be informed about the rules applying to passports and visas for countries within the EEA. It is the responsibility of the Guest to ensure that SkiStar is provided with the correct contact details of the Guest, including mobile number and e-mail address, as these details...
View Source
Agreement, Etc. This instrument contains the entire understanding of the parties with respect to the subject matter hereof, supersedes all other agreements between any of the parties with respect to the subject matter hereof and cannot be altered or otherwise amended except pursuant to an instrument in writing signed by the parties hereto as set forth in Section 18 below. This Agreement shall be interpreted under the laws of the State of California, without reference to its principles of conflicts of law.
View Source

Related to Agreement, Etc

  • Service Agreement Refers to the Contract, Purchase Order or Terms of Service or Terms of Use. Student Data: Student Data includes any data, whether gathered by Provider or provided by LEA or its users, students, or students’ parents/guardians, that is descriptive of the student including, but not limited to,

  • Agreement ▇▇▇ ▇▇▇▇ The Company shall not produce iron ore under this Agreement for transportation in any calendar year in excess of the approved production limit nor shall the total number of the mine workforce exceed the approved mine workforce without the prior consent in principle of the Minister and, subject to that consent, approval of detailed proposals in regard thereto in accordance with this Clause.

  • Arrangement Agreement This Plan of Arrangement is made pursuant to, and is subject to the provisions of, the Arrangement Agreement, except in respect of the sequence of the steps comprising the Arrangement, which shall occur in the order set forth herein.

  • Cooperation Agreement At the Closing, PCC and Buyer shall, and PCC shall cause PCC Parent to, execute and deliver the Cooperation Agreement pursuant to which Buyer, PCC Parent and PCC shall provide each other certain information and other assistance in connection with the collection, administration and/or satisfaction of certain of the Retained Liabilities.

  • Transition Agreement 12.8.1 In the event of termination of this Agreement, whether in its entirety or with respect to the Terminated Territory, Ablynx and AbbVie shall negotiate in good faith the terms and conditions of a written transition agreement (the “Transition Agreement”) pursuant to which AbbVie and Ablynx will effectuate and coordinate a smooth and efficient transition of relevant obligations and rights to Ablynx as reasonably necessary for Ablynx to exercise its licenses pursuant to Sections 12.6 and 12.7 with respect to the Licensed Products after termination of this Agreement (in its entirety or with respect to the Terminated Territory, as applicable) as and to the extent set forth in this Article 12. For purposes of clarity, AbbVie shall not be required to Manufacture or have Manufactured the Licensed Products by or on behalf of Ablynx as part of the Transition Agreement. CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 12.8.2 The Transition Agreement shall provide that in the event of a termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3 or by Ablynx in its entirety pursuant to Section 12.2.1, AbbVie shall: (i) where permitted by Applicable Law, transfer to Ablynx all of its right, title, and interest in all Regulatory Documentation then Controlled by AbbVie and in its name applicable to the Licensed Products in the Territory that are the subject of an exclusive license grant in Section 12.6.1(iii); (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) unless expressly prohibited by any Regulatory Authority, transfer control to Ablynx of all Clinical Studies being Conducted by AbbVie as of the effective date of termination and continue to Conduct such Clinical Studies, […***…], for up to […***…] to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Ablynx shall not have any obligation to continue any Clinical Study unless required by Applicable Law, in which case Ablynx, if it wishes to terminate such Clinical Study, shall continue such Clinical Study […***…] until such time that Applicable Law allows such trial to be terminated (with Ablynx taking all reasonable steps to promptly terminate such Clinical Study and minimize all costs and expenses), and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, […***…]; (iv) assign (or cause its Affiliates to assign) to Ablynx all agreements with any Third Party with respect to the conduct of pre-clinical Development activities, Manufacturing or Clinical Studies for the Licensed Products, including agreements with contract research organizations, contract manufacturing organizations, clinical sites, and investigators, unless, with respect to any such agreement, such agreement (a) expressly prohibits such assignment, in which case AbbVie shall cooperate with Ablynx in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (b) covers Clinical Studies for Combination Products in which any active ingredient that is not a Licensed Compound is covered by Patents Controlled by AbbVie or any of its Affiliates or covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Licensed Products, in which case AbbVie shall, […***…], cooperate with Ablynx in all reasonable respects to facilitate the execution of a new agreement between Ablynx and the applicable Third Party; and (v) transfer to Ablynx all existing clinical supplies of the Licensed Compound or Licensed Product in the possession of AbbVie at the time of termination, which shall be […***…]. CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. In the event this Agreement is partially terminated or terminated in its entirety by Ablynx pursuant Section 12.2.1, then any actions or activities set forth in the Transition Agreement shall be […***…]. 12.8.3 The Transition Agreement shall provide that in the event of a termination of this Agreement with respect to a country or other jurisdiction by AbbVie pursuant to Section 12.3.2 or with respect to a Terminated Territory by Ablynx pursuant to Section 12.2.2 (but not in the case of any termination of this Agreement in its entirety), AbbVie shall in a reasonable amount of time following Ablynx’s request: (i) where permitted by Applicable Law, transfer to Ablynx all of its right, title, and interest in all Regulatory Approvals owned by AbbVie and then in its name that is solely applicable to the Terminated Territory and to the Licensed Products that are the subject of an exclusive license grant in Section 12.7.2, as such Regulatory Approvals exists as of the effective date of such termination of this Agreement with respect to such Terminated Territory; provided, that AbbVie retains a license and right of reference under any Regulatory Approval transferred pursuant to this clause as necessary or reasonably useful for AbbVie to Commercialize Licensed Products in the Territory, Develop Licensed Products in support of such Commercialization, or Manufacture Licensed Products in support of such Development or Commercialization; (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) grant Ablynx a right of reference to all Regulatory Documentation then owned by AbbVie and in AbbVie’s name that are not transferred to Ablynx pursuant to clause (i) above that are necessary or reasonably useful for Ablynx, any of its Affiliates or sublicensees to Develop or Commercialize any Licensed Products that are the subject of the license grant in Section 12.7.2, as such Regulatory Documentation exists as of the effective date of such termination of this Agreement with respect to such Terminated Territory.